Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / RARE - Ultragenyx upgraded to buy at Guggenheim as stock trading at discount to biotech peers

RARE - Ultragenyx upgraded to buy at Guggenheim as stock trading at discount to biotech peers

Ultragenyx Pharmaceutical Inc.

  • Guggenheim has upgraded Ultragenyx Pharmaceutical ( NASDAQ: RARE ) to buy as the company is trading at a discount to its mid-cap biotech peers.
  • The firm has a $50 price target (~30% upside based on Wednesday's close).
  • Analyst Debjit Chattopadhyay said that the company's commercial franchise and pipeline provide "a floor for the stock close to the current trading level."
  • While a clinical update on GTX-102 for Angelman syndrome was underwhelming, Chattopadhyay said that the candidate "could still have legs."
  • Seeking Alpha's Quant Rating views Ultragenyx ( RARE ) as a strong sell.

For further details see:

Ultragenyx upgraded to buy at Guggenheim as stock trading at discount to biotech peers
Stock Information
Company Name: Ultragenyx Pharmaceutical Inc.
Stock Symbol: RARE
Market: NASDAQ
Website: ultragenyx.com
Menu
RARE RARE Quote RARE Short RARE News RARE Articles RARE Message Board
Get RARE Alerts

News, Short Squeeze, Breakout and More Instantly...